Business & Technology Briefs (05/2007)
Executive Summary
Brief summaries of recent product and company developments in the device industry, including J&J's shelving of Conor's CoStar Stent, new guidelines for treating atrial fibrilation, CMS' ruling on carotid stents, and Cyberonic's recent restructuring.
You may also be interested in...
ACC Wrap-Up: Device Companies Win a Few, Lose a Few
Several interesting studies came out of this year's joint meeting of the American College of Cardiology and Society for Cardiovascular Angiography and Interventions. These studies--many of them about drug-eluting stents--will impact device manufacturers in both positive and negative ways.
ACC Wrap-Up: Device Companies Win a Few, Lose a Few
Several interesting studies came out of this year's joint meeting of the American College of Cardiology and Society for Cardiovascular Angiography and Interventions. These studies--many of them about drug-eluting stents--will impact device manufacturers in both positive and negative ways.
Seizure Desist: Neurostim Companies Pursue Alternative Treatments for Epilepsy
The rise of interest in neurostimulation and neuromodulation approaches is leading venture capitalists and large medical device companies to develop devices to prevent or block seizures. The devices would be used primarily on patients who don't respond to drugs for epilepsy.